Sign in

Hashim Ahmed

@londonprostate1.bsky.social
302 followers 184 following 11 posts

Chair of Urology Lead, Section of Specialty Surgery Consultant Urological Surgeon Imperial London www.imperialprostate.org

PostsRepliesMedia
Reposted by Hashim Ahmed
Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 31/10/2025
Next CRSG meeting: 📅Fri 17 Apr 2026, 🚩London. Details 👇 🔗 prostatecanceruk.org/research/for...
Members of the Clinical Research Strategy Group at the Prostate Cancer UK headquarters
011
Reposted by Hashim Ahmed
Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 31/10/2025
🧵[5/6] 💡 Got a new trial idea to improve outcomes for men with prostate cancer? Use our form and submit your proposal Deadline: 4pm, Fri 13 Feb Applicants are encouraged to present their ideas and take part in the discussion at the next CRSG meeting. prostatecanceruk.org/research/for...
prostatecanceruk.org
UK Prostate Cancer Clinical Research Strategy Group
Keep up to date on the activities of the group, access forms and key dates.
122
Reposted by Hashim Ahmed
Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 31/10/2025
🧵[4/6] 🌱 Early-career clinical researchers — your opportunity is here! Apply for one of two CRSG observer roles to learn from leaders, connect nationally & grow your research career in prostate cancer. Deadline: 4pm, Fri 16 Jan
111
Reposted by Hashim Ahmed
Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 31/10/2025
🧵[3/6] 👥 We’re recruiting Full Members! Expertise wanted in: 🧬 Pathology 🏥 Primary care 💉 Research nursing 🩻 Radiology Join us in shaping UK prostate cancer clinical research. Deadline: 4pm, Fri 16 Jan
111
Reposted by Hashim Ahmed
Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 31/10/2025
🧵[2/6] The CRSG will shape clinical prostate cancer research by: 🔍 Identifying key research gaps 💪 Strengthening study design early 👏 Encouraging collaboration 🧑‍🎓 Mentoring early-career researchers
111
Reposted by Hashim Ahmed
Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 31/10/2025
🧵[1/6] 📣 Big news for clinical prostate cancer researchers! The NCRI Prostate Group has re-established as UK Prostate Cancer Clinical Research Strategy Group (CRSG) - a national hub for collaboration & innovation in prostate cancer research. Learn more 👇 prostatecanceruk.org/research/for...
142
Reposted by Hashim Ahmed
Imperial Medicine @imperialmed.bsky.social · 15/10/2025
As debate grows over targeted #ProstateCancer screening, experts call for careful evaluation. "We can often find disease that doesn't need to be treated and we end up causing harm" — Prof Hashim Ahmed (@londonprostate1.bsky.social) @imperialsandc.bsky.social www.bbc.co.uk/news/article...
bbc.co.uk
Rishi Sunak: Prostate cancer screening could 'save countless lives'
The former PM is among those in favour of targeted screening for men most at risk, but some medical experts are sceptical.
011
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 29/04/2025
Update of #IP7PACIFIC presented by @ajwlight.bsky.social at #AUA25 🇺🇸 This will be the first trial to provide definitive evidence comparing bpMRI vs mpMRI, alongside fusion vs cognitive biopsy >1200 patients recruited across the UK - watch this space
122
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 29/04/2025
Update of #IP9ATLAS presented by Archana Gopalakrishnan at #AUA25 🇺🇸 This pivotal RCT will evaluate MRI-based surveillance for patients with GG1-2 cancer starting active surveillance Recruitment is open across the UK!
031
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 29/04/2025
That’s a wrap on #AUA25 for Team IP! See you in Washington DC for #AUA26! 🇺🇸
031
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 27/04/2025
New publication alert! 🚨 A clinician survey on the current practices within the prostate cancer diagnostic pathway in the United Kingdom - Uma Walters et al (Journal of Clinical Urology) 🔗 doi.org/10.1177/2051...
032
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 27/04/2025
5yr outcomes following Rezum for >80mL prostates presented by @ajwlight.bsky.social (on behalf of Yan Leung) #AUA25 🇺🇸 Take home message - 3 of 4 patients were free of retreatment by 5 years
012
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 27/04/2025
Excellent podium presentation by our resident Chase Ng on >1200 patients in #RAPID discharged with negative MRI or biopsy Only 1 in 12 developed csPCa & 1 in 20 needed cancer treatment by 5 years More evidence of the oncological efficacy of pre-biopsy MRI! #AUA25 🇺🇸
031
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 27/04/2025
@ajwlight.bsky.social presents preliminary validation data on the #TARGET scoring system - good specificity and NPV for detecting GG2+ in-field disease Watch this space for our definitive multi centre validation study! #AUA25 🇺🇸
012
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 28/04/2025
Building on our #IP8FLUORESCE study is #IB1LaserCOMPLETE - using ex vivo fluoresce confocal microscopy to establish muscle status in TURBT, presented by Archana Gopalakrishnan Recruitment is under way - watch this space for results soon! #AUA25 🇺🇸
031
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 28/04/2025
In further #RAPID data, Chase Ng shows that patients discharged from a pre-biopsy MRI pathway with ASAP or HGPIN do not have a greater risk of subsequent csPCa or treatment than patients discharged without #AUA25 🇺🇸
011
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 27/04/2025
Powerful messages from @londonprostate1.bsky.social in the focal therapy plenary crossfire debate Most intermediate risk cases are suitable, focal therapy is very effective, and the functional outcomes are superior. Surgeon training is crucial! #AUA25 🇺🇸
131
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 28/04/2025
Pilot results from #IP2ATLANTA on novel cytoreductive treatments to the prostate & mets in de novo mHSPC presented by @londonprostate1.bsky.social #AUA25 🇺🇸 Take home - these treatments are safe and justified Recruitment for the main trial has completed - PFS endpoint to be reported 2027
011
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 02/04/2025
📢 Join us at @IP_London We are recruiting a Clinical Research Fellow to join the #IP13AVIDITY team: RCT evaluating the role of PSMA PET/CT in directing treatment in patients w/ high-risk PCa (closing 15/04) 🔗 www.imperial.ac.uk/jobs/search-... @londonprostate1.bsky.social @connorurol.bsky.social
imperial.ac.uk
Description
Please note that job descriptions are not exhaustive, and you may be asked to take on additional duties that align with the key responsibilities ment...
022
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 28/03/2025
💬 #TRANSFORM will look at new ways of screening to reduce false positives, reduce biopsy rates and reduce diagnosing low risk cancers whilst finding more high risk cancers that need treating. @londonprostate1.bsky.social @prostatecanceruk.bsky.social @nihr.bsky.social www.lbc.co.uk/opinion/view...
lbc.co.uk
I treat prostate cancer every day – now I'm launching a study that could transform screening and save lives
The debate on screening for prostate cancer has been raging for over two decades.
021
Reposted by Hashim Ahmed
Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 28/03/2025
Great to see Professor Hashim Ahmed @londonprostate1.bsky.social talking @nickferrarilbc.bsky.social through his PSA blood test this morning, and sharing why the TRANSFORM trial is vital for finding the best way to screen men for #ProstateCancer. prostatecanceruk.org/research/tra...
021
Hashim Ahmed @londonprostate1.bsky.social · 27/03/2025
Two weeks to go! Imperial Prostate Masterclass In association with Focal Therapy Society @ip-london.bsky.social www.imperialprostatemasterclass.org
130
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 24/03/2025
With presentations from 4 IP trials and multiple other projects, it’s been a fantastic #EAU25 for Imperial Prostate 🇪🇸 See you next year in London for #EAU26! 🇬🇧
021
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 24/03/2025
#IP2ATLANTA RCT pilot result #EAU25 🇪🇸 🔬 9 in 10 patients have a viable prostate tumour despite ADT+ARTA/Doce 🚦Early signal in prostate cancer mortality for cytoreductive arms 📈 Surgery, radiotherapy or ablation + SABR safe - Recruited (n=433) PFS exp.2027! @connorurol.bsky.social
021
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 24/03/2025
It’s a big last day at #EAU25 for our team! 🇪🇸 @connorurol.bsky.social - 2x #IP2ATLANTA pilot study results (12:00) Mr Chase Ng - #RAPID 5-yr follow-up for negative biopsy patients (12:05) Mr Nikhil Mayor - #IP8FLUORESCE late breaking results (12:15)
011
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 24/03/2025
Mr Chase Ng presents 5-year follow-up data for patients discharged with negative MRI/biopsy from our #RAPID pathway #EAU25 🇪🇸 1 in 12 were subsequently diagnosed with GG2+ cancer and 1 in 20 needed treatment - this further highlights the efficacy of MRI-based diagnostics!
011
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 24/03/2025
Building on this morning’s #NeuroSAFE data, @nikhilmayor.bsky.social presents late-breaking results from #IP8FLUORESCE, assessing the diagnostic accuracy of FCM for detecting positive margins intra-op Feasible, quick and good sensitivity and specificity for detecting margins ≥3mm! #EAU25 🇪🇸
052
Hashim Ahmed @londonprostate1.bsky.social · 23/03/2025
Nice work by Deepika! #EAU2025 #EAU25
010
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 23/03/2025
Lastly for Imperial Prostate today @ #EAU25 🇪🇸 is Ms Deepika Reddy in the new technologies & focal therapy in localised PCa session Traditional risk classification strategies developed for radical treatment are not transferrable to focal therapy outcomes. Risk models are in development!
022
Hashim Ahmed @londonprostate1.bsky.social · 23/03/2025
Well done Yan! #eau25 #eau2025 Rezum a good option for men with slightly larger glands
010
Hashim Ahmed @londonprostate1.bsky.social · 23/03/2025
Great job by @nikhilmayor.bsky.social on the TRANSFORM article in European Urology Today congress news magazine #EAU25 #EAU2025 @prostateukprofs.bsky.social @uroweb.bsky.social
010
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 23/03/2025
Excellent presentation by Miss Yan Leung on 5-year outcomes after Rezum in >80mL prostates #EAU25 🇪🇸 75% retreatment-free at 5 years and the majority satisfied with their treatment!
032
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 23/03/2025
And now @londonprostate1.bsky.social presents an update on the #TRANSFORM randomised prostate cancer screening study in the plenary session - recruitment starting later this year to answer some of the biggest questions in screening 📝📈 #EAU25
034
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 23/03/2025
👀 @IP_London @ #EAU25 today! Real world experience of Rezūm therapy (≥ 80g) - retreatment rates at 5 years follow up - Miss Yan Leung 📍Green Area EGPT1 ⏱️ 15:30 Outcomes of focal HIFU for localised PCa determined by modern risk stratification strategies - Ms Deepika Reddy 📍Green Area Rm3 ⏱️ 17:15
021
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 22/03/2025
📣 Join Clinical Lecturer Mr Martin Connor as he presents the first Imperial Prostate randomised controlled trial - #IP2ATLANTA internal pilot results are out! Live on Monday 12:00 ⏱️ #EAU25 🇪🇸 #CytoreductiveSurgery #SABR #Ablation @connorurol.bsky.social @londonprostate1.bsky.social
032
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 21/03/2025
Is bpMRI non-inferior to mpMRI? Is image-fusion biopsy superior to cognitive biopsy? @nikhilmayor.bsky.social gives an update on the #IP7PACIFIC trial with >1,000 patients recruited so far #EAU25 🇪🇸
0114
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 21/03/2025
Next is Dr Archana Gopalakrishnan discussing the #IP9ATLAS trial For active surveillance, is regular MRI superior to standard care for detecting progression? Recruitment is open and the trial will randomise 1263 patients in 30 centres. Watch this space! #EAU25 🇪🇸
032
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 21/03/2025
Next up: PhD Fellow @ajwlight.bsky.social presents an update from the multicentre blinded #IP8FLUORESCE study evaluating #ConfocalMicroscopy for margin status in #RadicalProstatectomy - recruitment complete and results out on Monday 24/03 at #EAU25 🇪🇸
043
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 21/03/2025
It’s a big first day at #EAU25 for our clinical trials & PhD fellows! 🚀 Come along at 15:15 to ‘On the horizon: Ongoing trials in urology’ in Green Area Retiro @nikhilmayor.bsky.social presenting #IP7PACIFIC @ajwlight.bsky.social presenting #IP8FLUORESCE Archana Gopalakrishnan presenting #IP9ATLAS
022
Reposted by Hashim Ahmed
Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 19/03/2025
Professor Hashim Ahmed @londonprostate1.bsky.social at @ip-london.bsky.social has shown that ultrasound could provide imaging-based #prostatecancer diagnosis for men who are unable to have an MRI scan. 📙Read more: buff.ly/A81eRvH
Multiparametric ultrasound could be a cheaper, quicker way of detecting clinically significant prostate cancer, especially for men who are unable to have MRI scans. Professor Hashim Ahmed, Imperial College London.
032
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 14/03/2025
"Is an RCT between Focal Therapy and Standard of Care a Pipe Dream?" — don't miss Professor Caroline Moore tackling this 🔥 topic during #ipftsmasterclass25 Don't miss out, register today! 🎟️🚨 📍 London, UK | 📅 11-12 April 2025 🔗 imperialprostatemasterclass.org
031
Reposted by Hashim Ahmed
Imperial Medicine @imperialmed.bsky.social · 12/03/2025
"Receiving funding from @prostateukprofs.bsky.social is allowing us to undertake this crucial work." Prof Hashim Ahmed (@londonprostate1.bsky.social) A £1.89m trial has launched to test if a new scan can improve treatments for high-risk prostate cancer patients. prostatecanceruk.org/about-us/new...
prostatecanceruk.org
£2m trial to test whether new scan could stop high-risk prostate cancer from spreading
The trial will test whether the new, more accurate scan can give men the targeted treatment they need to stop the spread of prostate cancer.
065
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 11/03/2025
🚨 We're launching the £1.89M #IP13AVIDITY trial to test PSMA PET/CT scans for detecting & escalating #ProstateCancer treatment funded by @prostateuk.bsky.social Co-led by @londonprostate1.bsky.social @connorurol.bsky.social #TaraBarwick #RhianGabe #AdamBrentnall 🗞️➡️ www.thetimes.com/uk/healthcar...
thetimes.com
‘Groundbreaking’ scan for men with prostate cancer could save lives
Researchers hope the technology will help to create personalised treatment plans to prevent the disease becoming terminal
163
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 11/03/2025
💬 "Whilst the new PSMA PET/CT scan does show up more areas, we do not yet know whether changing treatment based on the new scan actually makes a difference to survival. #IP13AVIDITY will give us that answer." @londonprostate1.bsky.social
041
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 07/03/2025
Prof. Hashim Ahmed joined Imperial College London as Professor & Chair of Urology 8️⃣ years (1️⃣3️⃣ clinical trials & countless research projects) ago! 🚀💫 🎉 Congratulations @londonprostate1.bsky.social, thank you for continuing to encourage and inspire all of us @imperialcollegeldn.bsky.social
151
Hashim Ahmed @londonprostate1.bsky.social · 05/03/2025
Inaccuracy of rapid at home PSA tests www.bbc.co.uk/news/article...
bbc.co.uk
Prostate cancer: Rapid at-home PSA tests spark concerns
Testing for PSA protein can indicate whether a man is at risk of prostate cancer.
021
Reposted by Hashim Ahmed
Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 26/02/2025
Prof Hashim Ahmed @londonprostate1.bsky.social at @ip-london.bsky.social designs clinical trials that report meaningful outcomes, ensuring valuable research funds are used to improve understanding of the best #prostatecancer treatments for men. 📙Read more: prostatecanceruk.org/research/res...
If we can confirm focal therapy is an effective treatment for cancer whilst maintaining a low side-effect profile, the potential impact to men with prostate cancer will be immense.  Overall, this would maintain not only their life expectancy but also quality of life.
Professor Hashim Ahmed, Imperial College London.
064
Reposted by Hashim Ahmed
Imperial Prostate @ip-london.bsky.social · 21/02/2025
We were honoured to have Professor Mark Emberton @uclh.bsky.social proctoring our first @imperialnhs.bsky.social IRE (Nanoknife) list yesterday - we couldn’t ask for a better mentor to guide us through! 🎯⚡️
041
Reposted by Hashim Ahmed
Shaun Lintern @shaunlintern.bsky.social · 09/02/2025
“It's been underinvested in, steadily, for years & years...across governments, across many years — and you have to see it to believe it" Outgoing @NHSEngland chair Richard Meddings talks to Sunday Times Oli Shah www.thetimes.com/uk/healthcar...
thetimes.com
I chaired the NHS and hardly believed it: sewage flows into sinks
The outgoing chairman of NHS England is full of praise for its staff but says the service is ‘sclerotic’ and relies too heavily on politicians
24324
Reposted by Hashim Ahmed
Jonathan Portes @jdportes.bsky.social · 09/02/2025
"Hence the urgency of implementing now the second part of the Conservatives policy - the encouragement of re-emigration." Wait - that's not @rcolvile.bsky.social below (though it's what he's arguing). It's Powell's Rivers of Blood speech. www.thetimes.com/comment/colu...
thetimes.com
It’s mad to give migrants leave to remain when we’ve no idea if they contribute
Britain cannot afford to give a route to long-term residency and citizenship to thousands or eventually millions of new arrivals who will cost the country
39412115